Median Technologies partners with Canon’s Olea Medical to commercialize eyonis LCS lung cancer screening softwarePUBT·2 hours agoCAJPY+0.64%TEM+4.28%
FDA panel approves expanded use of peptides in compounding pharmacies, raising concerns about prescription surge in billion-dollar industry.Unusual Whales·Jul 24 at 05:24 PMIXJ-1.35%BBH-1.47%
Dear Tempus AI Stock Fans, Mark Your Calendars for July 30Barchart Option·4 hours agoTEM+4.28%TEMT+9.28%
Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoringbenzinga_article·Jul 21 at 01:52 PMTEM+4.28%PSNL+2.90%
Are FNWD, PSNL, DSGR Obtaining Fair Deals for their Shareholders?PR Newswire·2 days ago, 06:39 PMFNWD+1.13%PSNL+2.90%
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision MedicineUnusual Whales·Jul 22 at 07:37 AMTEM+4.28%TEMT+9.28%
Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a "Market Misread"Tip Ranks·Jul 20 at 03:18 PMPSNL+2.90%TEM+4.28%
TEM: $1.5B acquisition combines MRD portfolios to drive growth, data synergies, and profitability by 2027Quartr·Jul 20 at 11:20 AMPSNL+2.90%TEM+4.28%
TEM: A $1.5B acquisition merges AI oncology and MRD tech to lead in cancer monitoringQuartr·Jul 20 at 07:36 AMTEM+4.28%TEMT+9.28%
13:42 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWDprnewswire·1 day ago, 12:42 PMFNWD+1.13%BLFS+0.49%
Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion dealPUBT·Jul 20 at 07:32 AMPSNL+2.90%TEM+4.28%
New AI ETF Bets on Healthcare's $9 Trillion Opportunitybenzinga_article·Jul 24 at 02:08 PMHLTH+0.33%CYTK+1.79%
Merck Reportedly Goes To Bat In Takeover Battle. But Genomics Stock Reverses.Unusual Whales·Jul 19 at 01:30 PMPSNL+2.90%MRK-0.81%
Hsbc Holdings PLC Makes New Investment in 10x Genomics $TXGMarket Beat·Jul 24 at 03:50 AMTXG+5.03%HSBA
